Log In
BCIQ
Print this Print this
 

CLL MASTR Plus

  Manage Alerts
Collapse Summary General Information
Company Multiplicom N.V.
DescriptionGenetic mutation kit
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsImprove diagnosis of patients with chronic lymphocytic leukemia (CLL)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today